Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Carbamate | HCID 276 | — |
| Reactant | Quinazoline | HCID 9210 | — |
| Reactant | Dimethylethylamine | HCID 11723 | — |
| Reactant | 7-[3-(4-Methyl-piperazin-1-yl)-propoxy]-4-piperidin-4-yl-quinazoline | HCID 12003706 | — |
| Reactant | (4-Morpholin-4-yl-phenyl)-carbamic acid 4-nitrophenyl ester hydrochloride | HCID 68947764 | — |
| Solvent | Dichloromethane methanol | HCID 21226129 | — |
| Product | 2-Nitrophenol | HCID 6947 | — |
| Product | Dimethylethylamine | HCID 11723 | — |
| Product | 4-{7-[3-(4-Methyl-piperazin-1-yl)-propoxy]-quinazolin-4-yl}-piperidine-1-carboxylic acid (4-morpholin-4-yl-phenyl)-amide | HCID 11975524 | — |
Reaction Steps
A solution of 7-[3-(4-Methyl-piperazin-1-yl)-propoxy]-4-piperidin-4-yl-quinazoline (3.654 g, 9.9 mmol), as prepared in the previous step, in 98:2 DCM/MeOH (15 mL) was added rapidly dropwise under air in 2 mL portions to an ice bath-chilled stirred mixture of (4-morpholin-4-yl-phenyl)-carbamic acid 4-nitro-phenyl ester hydrochloride (4.13 g, 10.9 mmol), as prepared in Example 66a, and dimethylethylamine (DMEA) (1.4 mL, 13 mmol) in 98:2 DCM/MeOH (20 mL). Residual quinazoline derivative was then transferred to the carbamate reaction mixture with 2×7 mL additional 98:2 DCM/MeOH. The resulting homogeneous dark amber solution was stirred for another 5 min, and the ice bath was then removed and the reaction stirred at “rt” for 1.5 hr. The homogeneous reaction solution was then directly applied to a silica flash column (79 mm diameter×6″ length) pre-equilibrated with acetone. The title compound was eluted with 1.5 L acetone→2 L 9:1 acetone/MeOH→2 L 9:1 acetone/MeOH/3% DMEA. The combined fractions were concentrated to afford the title compound contaminated with nitrophenol and DMEA, and this material was partitioned with DCM (100 mL) and 2 M aqueous K2CO3 (2×20 mL). The organic layer was dried (Na2SO4) and concentrated under high vacuum at 90° C. to afford the title compound as a lavender foam that was crushed to a powder [3.89 g, 70% over three steps from 4-(7-Fluoro-quinazolin-4-yl)-piperidine-1-carboxylic acid tert-butyl ester].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08071768B2 |
|---|
| Source dataset | uspto-grants-2011_12 |
|---|
| ORD ID | ord-05d2a809decf4363ae8f0ef26f33b174 |
|---|
| Source note | uspto-grants-2011_12 |
|---|